tiprankstipranks
Kwang Dong Pharmaceutical Co., Ltd. (KR:009290)
:009290
South Korea Market
009290
Kwang Dong Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Kwang Dong Pharmaceutical Co., Ltd. (009290) Financial Statements

― Followers

Kwang Dong Pharmaceutical Co., Ltd. Financial Overview

Kwang Dong Pharmaceutical Co., Ltd.'s market cap is currently ₩298.23B. The company's EPS TTM is ₩504.9; its P/E ratio is 12.56; and it has a dividend yield of 1.58%. Kwang Dong Pharmaceutical Co., Ltd. is scheduled to report earnings on August 12, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 1.66T₩ 1.64T₩ 1.51T₩ 1.43T₩ 1.34T
Gross Profit₩ 293.22B₩ 299.30B₩ 295.12B₩ 282.05B₩ 274.25B
Operating Income₩ 31.05B₩ 30.10B₩ 48.77B₩ 38.24B₩ 44.94B
EBITDA₩ 48.54B₩ 44.63B₩ 54.97B₩ 53.97B₩ 51.02B
Net Income₩ 20.97B₩ 40.48B₩ 36.97B₩ 24.17B₩ 24.02B
Balance Sheet
Cash & Short-Term Investments₩ 227.69B₩ 165.45B₩ 206.18B₩ 208.63B₩ 187.70B
Total Assets₩ 1.32T₩ 1.17T₩ 1.08T₩ 932.02B₩ 883.85B
Total Debt₩ 303.21B₩ 285.92B₩ 235.64B₩ 138.01B₩ 132.05B
Net Debt₩ 162.22B₩ 169.73B₩ 158.30B₩ 34.45B₩ 48.08B
Total Liabilities₩ 605.55B₩ 552.01B₩ 490.02B₩ 384.98B₩ 356.60B
Stockholders' Equity₩ 655.58B₩ 579.12B₩ 544.62B₩ 517.33B₩ 499.18B
Cash Flow
Free Cash Flow₩ 57.11B₩ -89.95B₩ -46.89B₩ 36.78B₩ 30.49B
Operating Cash Flow₩ 82.34B₩ -12.15B₩ -11.73B₩ 62.82B₩ 54.94B
Investing Cash Flow₩ -102.58B₩ 12.77B₩ -71.83B₩ -42.75B₩ -42.98B
Financing Cash Flow₩ 45.52B₩ 36.76B₩ 58.01B₩ -628.26M₩ 15.89B
Currency in KRW

Kwang Dong Pharmaceutical Co., Ltd. Earnings and Revenue History

Income Statement >

Kwang Dong Pharmaceutical Co., Ltd. Debt to Assets

Balance Sheet >

Kwang Dong Pharmaceutical Co., Ltd. Cash Flow

Cash Flow >

Kwang Dong Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

Earnings >